NewsBenzingaResMed、第1四半期調整後EPSは2.91ドルで予想2.67ドルを上回る、売上高は14.15億ドルで予想13.92億ドルを上回る ResMed、第1四半期調整後EPSは2.91ドルで予想2.67ドルを上回る、売上高は14.15億ドルで予想13.92億ドルを上回る Benzinga 2026.10.29 20:05 (GMT+0) Open on Benzinga Other news CalPERS Discloses $37.1 Million Stake in Strategy Scammers Used Musk Deepfake Video to Defraud; Coinbase AI System Blocked $4.7 Million JPMorgan Is Developing AI Agent Trading Without Human Involvement Coinbase CEO: AI Agents to Account for Well Over 99.9% of Trading Volume Within a Decade; Bitcoin May Have Bottomed This Cycle Jito CEO: Crypto Developers Should Slow Down in the Next Two Years and Focus on Fixing Security Flaws Glassnode: Bitcoin Sell-Off Nears Historical Local Bottom Levels, $62,000 Becomes Key Line of Defense
Coinbase CEO: AI Agents to Account for Well Over 99.9% of Trading Volume Within a Decade; Bitcoin May Have Bottomed This Cycle
Jito CEO: Crypto Developers Should Slow Down in the Next Two Years and Focus on Fixing Security Flaws
Glassnode: Bitcoin Sell-Off Nears Historical Local Bottom Levels, $62,000 Becomes Key Line of Defense